Notes on Coronary Heart Disease and Angina Management

Introduction to Coronary Heart Disease

  • Definition of Coronary Heart Disease (CHD): This is a condition characterized by a decreased blood flow to the heart muscle, primarily due to the accumulation of fatty deposits or plaque leading to a process called atherosclerosis in the coronary arteries. This gradual hardening and narrowing of the arteries can lead to significant complications, including myocardial infarction (heart attack).

  • Angina Pectoris: Angina is a type of chest pain that occurs when there is insufficient oxygen (O2) supply to the heart muscle. It arises from an imbalance between oxygen supply and demand, particularly during physical exertion or stress. Different types of angina manifest under varying conditions, indicating the severity and nature of the underlying CHD.

Learning Objectives

  • Describe the clinical manifestations of CHD and its most common type of chest pain, angina, as patients experience it in everyday scenarios.

  • Understand the various drug classes that are utilized in the treatment of angina, their mechanisms of action, potential adverse effects, limitations, and patient considerations for each class to develop a comprehensive approach to therapy.

Types of Angina

  • Stable Angina (Classic): This form of angina is predictable, occurring with physical exertion, stress, or emotional upset. Patients typically describe a tight or squeezing sensation in the chest that can radiate to the arms, jaw, or back. It is often associated with significant coronary artery disease and usually resolves with rest or nitroglycerin administration.

  • Variant Angina (Prinzmetal’s): This type of angina is caused by coronary vasospasm, leading to transient ischemic episodes. It can occur unexpectedly, often at rest or during sleep, and is usually not associated with exertion or stress. The exact mediator of the vasospasm remains unclear, but treatment options typically include nitrates or calcium channel blockers (CCBs).

  • Unstable Angina: This form represents a medical emergency and is characterized by angina that occurs at rest or with minimal exertion. It may last longer than typical episodes of stable angina and indicates an increased risk of myocardial infarction. Patients may describe their symptoms as more severe and prolonged, often requiring urgent medical intervention.

Oxygen Supply and Demand

  • Oxygen Supply: The blood flow to the myocardium is critically dependent on coronary artery flow. Several factors can enhance oxygen supply, including:

    • Dilation of coronary arteries: This can be achieved pharmacologically through nitrates or naturally through exercise.

    • Reduced heart rate: A decrease in heart rate reduces myocardial oxygen consumption, allowing more oxygen to be available to the heart muscle.

  • Oxygen Demand: This is influenced by the heart's workload. Key determinants include:

    • Cardiac Output (CO): Defined as the amount of blood the heart pumps per minute, calculated as Heart Rate (HR) multiplied by Stroke Volume (SV).

    • Preload and Afterload: Preload is the volume of blood in the ventricles at the end of diastole, while afterload refers to the resistance the heart must overcome to eject blood. High preload or afterload increases the heart's workload, leading to increased oxygen demand.

Goals of Treatment for Stable Angina

  • The primary goals in managing stable angina are to:

    • Prevent anginal attacks and relieve acute symptoms when they occur.

    • Prevent the progression of coronary heart disease and reduce the risk of myocardial infarction.

    • Utilize pharmacological agents to either enhance oxygen supply to the heart muscle or decrease the demand for oxygen through various mechanisms.

Pharmacological Treatments for Stable Angina

  • Nitrates: These drugs undergo biotransformation, leading to the release of nitric oxide (NO). This action stimulates guanylate cyclase and increases cGMP, promoting vascular relaxation and hence enhancing blood flow to the heart.

    • Administration: Nitrates can be administered as short-acting formulations (e.g., sublingual tablets for acute relief during an angina attack) or longer-acting forms (such as isosorbide dinitrate) for prophylactic use.

    • Adverse Effects: Common side effects include headaches, flushing, and postural hypotension. Tolerance can develop with continuous nitrates usage, necessitating dosing strategies to mitigate this.

  • Beta-Blockers: These agents block sympathetic stimulation (specifically beta-1 receptors) to lower heart rate and myocardial contractility, which can alleviate angina episodes.

    • Adverse Effects: Possible adverse effects include bradycardia, fatigue, and a risk of bronchoconstriction, particularly in asthmatic patients. Careful monitoring is essential, especially when initiating therapy.

  • Calcium Channel Blockers (CCBs): These medications inhibit calcium entry into cells, leading to decreased heart rate and reduced vascular resistance, thereby alleviating angina.

    • Types: CCBs include both cardiac selective (like Verapamil) and vascular selective (such as Nifedipine) agents.

    • Adverse Effects: Side effects can include headache, flushing, and bradycardia (especially with Verapamil). Patients should be educated on managing potential side effects.

  • Ivabradine: This drug selectively reduces heart rate without adversely affecting myocardial contractility, making it useful in managing stable angina patients with a resting heart rate above 70 bpm.

    • Adverse Effects: May cause bradycardia and visual disturbances, necessitating clinical oversight during therapy initiation.

Treatment Strategies for Other Forms of Angina

  • Variant Angina: For variant angina, short-acting nitrates or prophylactic calcium channel blockers are the mainstay of therapy, while beta-blockers are typically contraindicated due to the risk of exacerbating vasospasm.

  • Unstable Angina: Management follows the principles of stable angina treatment, with the addition of antiplatelet agents like aspirin to prevent thrombus formation and reduce the risk of myocardial infarction.

Conclusion

  • Effective management of coronary heart disease requires a combination of strategies aimed at enhancing oxygen supply while minimizing demand. This approach integrates medication with lifestyle changes, patient education, and management of coexisting risk factors such as hypertension, hyperlipidemia, and diabetes. Continuous follow-up and adjustment of treatment regimens based on patient response and tolerance are crucial for optimal care in CHD patients.